RemSleep Holdings (RMSL) Research & Development (2010 - 2025)
RemSleep Holdings recorded quarterly Research & Development of $1500.0 in Q2 2025, down 91.28% quarter-over-quarter from $17200.0 in Q1 2025, and down 98.86% year-over-year from $132020.0 in Q2 2024.
RemSleep Holdings' Research & Development history runs 8 years deep, the most recent figure standing at $1500.0 for Q2 2025.
- In Q2 2025, Research & Development fell 98.86% year-over-year to $1500.0; the TTM figure through Sep 2025 stood at $9350.0 (down 97.66% YoY), while the FY2024 annual figure was $187445.0, down 36.42% from the prior year.
- Research & Development came in at $1500.0 for Q2 2025 at RemSleep Holdings, down from $17200.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $205220.0 in Q4 2023 to a low of -$9350.0 in Q4 2024.
- A 5-year average of $55409.6 and a median of $30242.5 in 2021 frame the typical range for Research & Development.
- Across the five-year window, Research & Development soared 1632.43% in 2021 and sank 104.56% in 2024, its largest moves.
- RemSleep Holdings' Research & Development stood at $33703.0 in 2021, then surged by 351.43% to $152145.0 in 2022, then surged by 34.88% to $205220.0 in 2023, then tumbled by 104.56% to -$9350.0 in 2024, then surged by 116.04% to $1500.0 in 2025.
- According to Business Quant data, Research & Development over the past three periods registered $1500.0, $17200.0, and -$9350.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,500.00 |
| Mar 31, 2025 | 17,200.00 |
| Dec 31, 2024 | -9,350.00 |
| Sep 30, 2024 | 40,775.00 |
| Jun 30, 2024 | 132,020.00 |
| Mar 31, 2024 | 22,188.00 |
| Dec 31, 2023 | 205,220.00 |
| Sep 30, 2023 | 13,887.00 |
| Jun 30, 2023 | 48,930.00 |
| Mar 31, 2023 | 26,782.00 |
| Dec 31, 2022 | 152,145.00 |
| Sep 30, 2022 | 121,170.00 |
| Jun 30, 2022 | 38,051.00 |
| Mar 31, 2022 | 25,667.00 |
| Dec 31, 2021 | 33,703.00 |
| Sep 30, 2021 | 16,666.00 |
| Dec 31, 2020 | 24,686.00 |
| Sep 30, 2020 | 962.00 |
| Jun 30, 2020 | 36,294.00 |
| Sep 30, 2012 | 10,250.00 |
| Jun 30, 2012 | 10,451.00 |
| Dec 31, 2010 | 177,587.00 |
| Sep 30, 2010 | 9,517.00 |